Alberta-developed drug could help prevent long COVID

Health Matters February 2: Calgary company Resverlogix has developed a drug that could not only stop COVID-19 illness from progressing, it also has potential to prevent chronic symptoms, or long COVID. As Su-Ling Goh reports, the pill is now in Phase 2 trials in Edmonton.